
Ensocell Therapeutics
Hinxton, UK
Ensocell Therapeutics, founded in 2023, specializes in precision biologics for autoimmune and fibrotic diseases. The company is headquartered in Hinxton, UK, and is in the drug discovery and target identification phase with approximately 21 employees.
Problem Statement
Treatment of rare monogenic diseases
Core Technology
Precision Biologics
Key Differentiators
Precision biologics
Clinical Focus
Immunology; Fibrosis
Company Info
- Business Model
- Platform
- Founded
- 2023
- Total Funding
- 16,300,000
- Website
- ensocell.com
Categories
Technologies
MedStartr Index Score
?What do you think of Ensocell Therapeutics?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.